Market Research Logo

Pneumococcal Vaccines Market: North America to Register Fastest Growth During the Forecast Period: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028

Pneumococcal Vaccines Market: North America to Register Fastest Growth During the Forecast Period: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028

Future Market Insights (FMI) offers a 10-year forecast on the global pneumococcal vaccines market. The primary objective of the report is to offer updates and information related to opportunities in the global pneumococcal vaccines market.

Report Description

In terms of revenue, the global pneumococcal vaccines market is expected to register a CAGR of 9.1% during the forecast period of 2018–2028. The primary objective of the report is to offer insights on the market dynamics that can influence the growth of the global pneumococcal vaccines market over the forecast period. Insights on the key trends, drivers, restraints, value forecasts and opportunities for companies operating in the global pneumococcal vaccines market are presented in the report.

The global demand for pneumococcal vaccines is increasing as a result of the large burden of pneumonia-related child mortality rate. Pneumonia is the leading cause of child deaths. 16% of all deaths under age 5 are due to pneumonia. The governments across the globe are focusing on reducing the mortality rate with the help of pneumococcal immunization, which is expected to fuel the growth of the pneumococcal vaccines market. Besides, the support from Gavi to low-income countries for pneumococcal immunization is expected to boost the growth of the pneumococcal vaccines market. Availability of cost-effective vaccines in developing countries as well as favourable reimbursement policies for pneumococcal conjugate and polysaccharide vaccine are expected to spur the demand for pneumococcal vaccines.

Research & development activities for the development of new pneumococcal vaccines, balanced supply and demand, government and private funding for pneumococcal vaccines are expected to boost the demand for pneumococcal vaccines over the forecast period. Manufacturers are focusing on mergers and collaborations for the development of new vaccines, whereas increasing pharmacy-based pneumococcal immunization is expected to create huge opportunities for growth of the pneumococcal vaccines market.

The revenue of the pneumococcal vaccines market in North America is expected to grow at the high rate. To understand and assess opportunities in this market, the report offers the market forecast on the basis of product type and distribution channel. The report provides analysis of the global pneumococcal vaccines market in terms of market value (US$ Mn).

The report begins with the market definition, followed by definitions of the different pneumococcal vaccines types. The market dynamics section includes FMI’s analysis on key trends, drivers, restraints, opportunities and macro-economic factors influencing the growth of the global pneumococcal vaccines market. Opportunity analysis provided in the section allows clients to better equip with crystal clear decision-making insights

The subsequent section of the report provides analysis of the market on the basis of regions and presents forecast in terms of value for the next 10 years. The regions covered in the report include:

North America

U.S.

Canada

Latin America

Brazil

Mexico

Rest of Latin America

Western Europe

Germany

Italy

France

Spain

U.K.

Rest of Western Europe

Eastern Europe

Russia

Poland

Rest of Eastern Europe

Asia Pacific Excluding Japan

India

China

ASEAN

Australia & New Zealand

Rest of APEJ

Japan

Middle East & Africa (MEA)

GCC Countries

South Africa

Rest of MEA

The next section provides competitive edge of the global pneumococcal vaccines market. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to a market segment in the pneumococcal vaccines market. The competition landscape section provides dashboard view of the activities of major players in the global pneumococcal vaccines market. The company profiles section provides information on the key offerings of each player in the global pneumococcal vaccines market, their direct & indirect presence, revenue, key developments and strategies and SWOT analysis. The key players included in this report are Pfizer Inc., Sanofi S.A., GlaxoSmithKline Plc., Merck & Co., Inc.

The next section analyses the market on the basis of product type and presents the forecast in terms of value (US$ Mn) for the next 10 years. The product types covered in the report include:

Pneumococcal Polysaccharide Vaccines

Pneumococcal Conjugate Vaccines

The next section analyses the market on the basis of the distribution channel and presents forecast in terms of value (US$ Mn) for the next 10 years. The distribution channels covered in the report include:

Pharmacies

Community Clinics

Public Health Agencies

Others

In addition, we have considered Year-on-Year (Y-o-Y) growth to understand the predictability of the market and identify growth opportunities for companies operating in the global pneumococcal vaccines market.

Another key feature of this report is the analysis of the key segments in terms of absolute dollar opportunity. This is usually overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective for services offered by pneumococcal vaccines market. To understand the key segments in terms of their growth and performance in the global pneumococcal vaccines market, Future Market Insights has developed a market attractiveness index. The resulting index will help providers to identify the existing market opportunities.


1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Pneumococcal Vaccines Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Market Background
4.1. Market Dynamics
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Key Trends
5. Key Inclusions
5.1. Disease Epidemiology
5.2. Reimbursement Scenario
5.3. Pipeline Assessment
6. Respiratory Syncytial Virus (RSV) Vaccines Market, Pipeline Assessment
7. North America Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2017
7.2.1. U.S.
7.2.2. Canada
7.3. Market Size (US$ Mn) Forecast By Country, 2018–2028
7.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
7.4.1. Pneumococcal Conjugate Vaccines
7.4.2. Pneumococcal Polysaccharide Vaccines
7.5. Market Size (US$ Mn) Forecast By Product Type, 2018–2028
7.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
7.6.1. Pharmacies
7.6.2. Community Clinics
7.6.3. Public Health Agencies
7.6.4. Others
7.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028
7.8. Market Attractiveness Analysis
7.8.1. By Country
7.8.2. By Product
7.8.3. By Distribution Channel
7.9. Key Market Participants – Intensity Mapping
8. Latin America Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028
8.1. Introduction
8.2. Historical Market Size (US$ Mn) By Country, 2013–2017
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Market Size (US$ Mn) Forecast By Country, 2018–2028
8.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
8.4.1. Pneumococcal Conjugate Vaccines
8.4.2. Pneumococcal Polysaccharide Vaccines
8.5. Market Size (US$ Mn) Forecast By Product Type, 2018–2028
8.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
8.6.1. Pharmacies
8.6.2. Community Clinics
8.6.3. Public Health Agencies
8.6.4. Others
8.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028
8.8. Market Attractiveness Analysis
8.8.1. By Country
8.8.2. By Product
8.8.3. By Distribution Channel
8.9. Key Market Participants – Intensity Mapping
9. Western Europe Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028
9.1. Introduction
9.2. Historical Market Size (US$ Mn) By Country, 2013–2017
9.2.1. Germany
9.2.2. France
9.2.3. U.K.
9.2.4. Spain
9.2.5. Italy
9.2.6. Rest of Western Europe
9.3. Market Size (US$ Mn) Forecast By Country, 2018–2028
9.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
9.4.1. Pneumococcal Conjugate Vaccines
9.4.2. Pneumococcal Polysaccharide Vaccines
9.5. Market Size (US$ Mn) Forecast By Product Type, 2018–2028
9.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
9.6.1. Pharmacies
9.6.2. Community Clinics
9.6.3. Public Health Agencies
9.6.4. Others
9.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028
9.8. Market Attractiveness Analysis
9.8.1. By Country
9.8.2. By Product
9.8.3. By Distribution Channel
9.9. Key Market Participants – Intensity Mapping
10. Eastern Europe Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028
10.1. Introduction
10.2. Historical Market Size (US$ Mn) By Country, 2013–2017
10.2.1. Russia
10.2.2. Poland
10.2.3. Rest of Eastern Europe
10.3. Market Size (US$ Mn) Forecast By Country, 2018–2028
10.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
10.4.1. Pneumococcal Conjugate Vaccines
10.4.2. Pneumococcal Polysaccharide Vaccines
10.5. Market Size (US$ Mn) Forecast By Product Type, 2018–2028
10.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
10.6.1. Pharmacies
10.6.2. Community Clinics
10.6.3. Public Health Agencies
10.6.4. Others
10.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028
10.8. Market Attractiveness Analysis
10.8.1. By Country
10.8.2. By Product
10.8.3. By Distribution Channel
10.9. Key Market Participants – Intensity Mapping
11. Asia Pacific excluding Japan and China (APEJ) Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028
11.1. Introduction
11.2. Historical Market Size (US$ Mn) By Country, 2013–2017
11.2.1. India
11.2.2. China
11.2.3. Australia and New Zealand
11.2.4. ASEAN
11.2.5. Rest of APEJ
11.3. Market Size (US$ Mn) Forecast By Country, 2018–2028
11.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
11.4.1. Pneumococcal Conjugate Vaccines
11.4.2. Pneumococcal Polysaccharide Vaccines
11.5. Market Size (US$ Mn) Forecast By Product Type, 2018–2028
11.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
11.6.1. Pharmacies
11.6.2. Community Clinics
11.6.3. Public Health Agencies
11.6.4. Others
11.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028
11.8. Market Attractiveness Analysis
11.8.1. By Country
11.8.2. By Product
11.8.3. By Distribution Channel
11.9. Key Market Participants – Intensity Mapping
12. Japan Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
12.2.1. Pneumococcal Conjugate Vaccines
12.2.2. Pneumococcal Polysaccharide Vaccines
12.3. Market Size (US$ Mn) Forecast By Product Type, 2018–2028
12.4. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
12.4.1. Pharmacies
12.4.2. Community Clinics
12.4.3. Public Health Agencies
12.4.4. Others
12.5. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Distribution Channel
12.7. Key Market Participants – Intensity Mapping
13. MEA Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028
13.1. Introduction
13.2. Market Size (US$ Mn) Forecast By Country, 2018–2028
13.3. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
13.3.1. Pneumococcal Conjugate Vaccines
13.3.2. Pneumococcal Polysaccharide Vaccines
13.4. Market Size (US$ Mn) Forecast By Product Type, 2018–2028
13.5. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
13.5.1. Pharmacies
13.5.2. Community Clinics
13.5.3. Public Health Agencies
13.5.4. Others
13.6. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028
13.7. Market Attractiveness Analysis
13.7.1. By Country
13.7.2. By Product
13.7.3. By Distribution Channel
13.8. Key Market Participants – Intensity Mapping
14. Forecast Factors: Relevance and Impact
15. Drivers and Restraints: Impact Analysis
16. Macroeconomic Assumptions
17. Market Share Analysis
18. Competition Analysis
18.1. Competition Dashboard
18.2. Company Deep Dive
18.2.1. Pfizer Inc.
18.2.1.1. Overview
18.2.1.2. Product Portfolio
18.2.1.3. Production Footprint
18.2.1.4. Sales Footprint
18.2.1.5. Strategy
18.2.1.5.1. Marketing Strategy
18.2.1.5.2. Product Strategy
18.2.1.5.3. Channel Strategy
18.2.2. Merck & Co., Inc.
18.2.2.1. Overview
18.2.2.2. Product Portfolio
18.2.2.3. Production Footprint
18.2.2.4. Sales Footprint
18.2.2.5. Strategy
18.2.2.5.1. Marketing Strategy
18.2.2.5.2. Product Strategy
18.2.2.5.3. Channel Strategy
18.2.3. GlaxoSmithKline plc.
18.2.3.1. Overview
18.2.3.2. Product Portfolio
18.2.3.3. Production Footprint
18.2.3.4. Sales Footprint
18.2.3.5. Strategy
18.2.3.5.1. Marketing Strategy
18.2.3.5.2. Product Strategy
18.2.3.5.3. Channel Strategy
18.2.4. Sanofi SA
18.2.4.1. Overview
18.2.4.2. Product Portfolio
18.2.4.3. Production Footprint
18.2.4.4. Sales Footprint
18.2.4.5. Strategy
18.2.4.5.1. Marketing Strategy
18.2.4.5.2. Product Strategy
18.2.4.5.3. Channel Strategy
19. Global Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028, By Region
19.1. Introduction / Key Findings
19.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2013–2017
19.2.1. North America
19.2.2. Western Europe
19.2.3. Eastern Europe
19.2.4. Latin America
19.2.5. Asia Pacific excluding Japan
19.2.6. Japan
19.2.7. Middle East and Africa
19.3. Market Size (US$ Mn) Forecast By Region, 2018–2028
19.4. Market Attractiveness Analysis By Region
20. Global Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028, By Product
20.1. Introduction
20.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
20.2.1. Pneumococcal Conjugate Vaccines
20.2.2. Pneumococcal Polysaccharide Vaccines
20.3. Market Size (US$ Mn) Forecast By Product Type, 2018–2028
20.4. Market Attractiveness Analysis By Product Type
21. Global Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel
21.1. Introduction
21.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
21.2.1. Pharmacies
21.2.2. Community Clinics
21.2.3. Public Health Agencies
21.2.4. Others
21.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028
21.4. Market Attractiveness Analysis By Distribution Channel
22. Global Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028
22.1. Market Value Share Analysis
22.1.1. By Country
22.1.2. By Product
22.1.3. By Distribution Channel
22.2. Y-o-Y Growth Analysis
22.2.1. By Country
22.2.2. By Product
22.2.3. By Distribution Channel
22.3. Absolute $ Opportunity
23. Assumptions and Acronyms
24. Research Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report